Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension

P Demelo-Rodriguez… - Heart Failure …, 2023 - heartfailure.theclinics.com
Pulmonary embolism (PE) and deep vein thrombosis are the main clinical manifestations of
venous thromboembolism (VTE). Acute PE is the third most common acute cardiovascular …

Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension.

P Demelo-Rodriguez, F Galeano-Valle… - Heart Failure …, 2023 - europepmc.org
Pulmonary hypertension (PH), in particular pulmonary arterial hypertension and chronic
thromboembolic PH, burdens patients with relevant morbidity and mortality. The use of oral …

Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension

P Demelo-Rodriguez, F Galeano-Valle… - Heart failure …, 2023 - pubmed.ncbi.nlm.nih.gov
Pulmonary hypertension (PH), in particular pulmonary arterial hypertension and chronic
thromboembolic PH, burdens patients with relevant morbidity and mortality. The use of oral …

Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension

P Demelo-Rodriguez - … in Pulmonary Hypertension, An Issue of …, 2022 - books.google.com
Pulmonary embolism (PE) and deep vein thrombosis are the main clinical manifestations of
venous thromboembolism (VTE). Acute PE is the third most common acute cardiovascular …

Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension

P Demelo-Rodriguez, F Galeano-Valle… - HEART FAILURE …, 2023 - air.unimi.it
Pulmonary hypertension (PH), in particular pulmonary arterial hypertension and chronic
thromboembolic PH, burdens patients with relevant morbidity and mortality. The use of oral …

[引用][C] Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension

P Demelo-Rodriguez… - Use of Oral …, 2023 - produccioncientifica.ucm.es